Skip to content
Visit the website
Organization profile · Non-invasive neuromodulation device

Nurosym

Parasym's auricular vagus nerve stimulation device · Nurosym in UK and European markets · Nuropod in the US, Canada, Australia and New Zealand

A handheld electrical stimulation device with an ear electrode, sold by Parasym for guided daily use without an app or recurring subscription.

Ireland storefront price
Nurosym returns
30 days after receipt
Device warranty
Two years
Subscription
None stated
Device, regional access, returns and evidence record checkedReviewed

What it is

Overview

Nurosym is Parasym's non-invasive auricular vagus nerve stimulation device, which the company calls AVNT. A handheld controller drives an earpiece electrode placed on a specified outer-ear site, and the user sets a comfortable intensity for each daily session.

Parasym sells the same core device under two regional names: Nurosym through its UK and European storefronts, and Nuropod in the United States, Canada, Australia and New Zealand. The technology is shared; price, return terms, warranty handling and market authorization follow the storefront where you buy.

At a glance

Nurosym is Parasym Ltd's ear-stimulation device, sold as Nuropod in some markets.

Company
UK company 10923314, incorporated in 2017 and registered in London.
Founders
Sophie Dundovic and Nathan Dundovic
Publicly associated with Parasym's founding and leadership.
Clinical and science team
Dr Elisabetta Burchi and Dr Greta Dalle Luche
Named on current company and product materials.
Regional name
The same core Parasym AVNT device, sold under this name in the United States, Canada, Australia and New Zealand with its own storefront terms.

Company claims

  • Calm and energy

    Nurosym markets its vagus-nerve stimulation device for lasting calm and more consistent energy.

Purchase cost

Pricing and ownership

Current consumer price

Other Nurosym countries and the Nuropod storefront set their own currency and price.

on the Nurosym Ireland storefront

Price and return terms are set per storefront; choose your country before comparing.

  • Nurosym AVNT system

    One-time kit price on the Ireland storefront; no app or recurring subscription is stated. Regional tax and shipping can differ.

    View the Nurosym system
  • Professional access

    Scope and pricing depend on the organization and market.

    Contact for terms
    Explore professional access

Ireland storefront and regional selector checked 31 August 2026; the selected storefront and checkout govern final price.

Fit → adjust → complete a session

How use works

Correct ear placement and comfortable intensity are central to the device routine.

  1. Review suitability

    Read the current contraindications and seek clinical advice when an implanted device, pregnancy, heart condition or other listed issue applies.

  2. Place the earpiece

    Follow the illustrated instructions for the specified outer-ear placement rather than moving the electrode to another site.

  3. Set a comfortable intensity

    Increase gradually until stimulation is perceptible but comfortable, following the current product guide.

  4. Complete and record the session

    Use the published session routine and note comfort or unexpected effects before repeating it.

Electrical stimulation + ear electrode

The ear-stimulation routine

Nurosym delivers low-level electrical stimulation through an electrode placed on the outer ear.

  • Electrode

    Auricular placement

    The earpiece targets a specified external-ear site associated with an auricular branch of the vagus nerve.

    The placement illustrated in the Nurosym guide is specific to this earpiece.

  • Controller

    User-adjustable intensity

    The handheld device allows the user to increase or decrease stimulation within its programmed range.

    Stronger sensation is not evidence of greater benefit and may reduce tolerability.

  • Routine

    App-free daily use

    The current system is operated directly from the controller without an app or paid subscription.

    Session controls are on the handheld unit.

Where + how to access

Regional access, returns and warranty

Country selection matters because Parasym sells the same core device under two regional names, each with its own storefront terms.

Nurosym markets
Use the site selector to confirm current shipping and currency.
Nuropod markets
Parasym sells the same core AVNT device as Nuropod in the United States, Canada, Australia and New Zealand; that storefront sets its own price, returns and warranty handling.
Nurosym returns
Request the return within 30 days after the device arrives; condition and packaging requirements apply and the customer pays return shipping.
Warranty
Two years device · six months electrode
Confirm regional coverage and exclusions at purchase.
Nuropod returns
A separate Nuropod term; confirm it against Nuropod's governing return policy at checkout.

Publicly identified people

Founders and clinical leadership

Parasym publicly connects Nurosym to its founders and clinical-science team.

Co-founder and chief executive

Sophie Dundovic

Publicly identified leader of Parasym.

Co-founder

Nathan Dundovic

Publicly associated with the company's founding and product development.

Clinical and scientific leadership

Dr Elisabetta Burchi

Named in current Nurosym clinical materials.

Clinical and scientific team

Dr Greta Dalle Luche

Named in current Nurosym clinical materials.

What the record shows

Certification, research and limits

Parasym publishes human studies and a CE-certification statement. Its research library includes both studies of its own devices and wider vagus-nerve stimulation research.

What is documented

  • The company states that Nurosym is CE certified and publishes a certification explainer.

  • Its evidence library includes randomized and prospective human research alongside wider neuromodulation literature.

What remains uncertain

  • The public certification page does not provide a complete certificate, notified-body record, device class and intended-purpose document for independent verification.

  • Some device-associated studies are small or single-group, and results should not be generalized beyond the studied population and protocol.

  • Nurosym's terms state that U.S. health claims have not been evaluated by the FDA. Confirm the product and regulatory status for your region before buying.

Independent coverage

Selected coverage

Independent coverage has examined consumer vagus-nerve stimulation while noting the still-developing evidence base.

Consumer technology coverage

A useful outside view of the category and Nurosym experience.

Decision guide

Before buying or booking

Region, suitability and the return clock are the practical checks before ordering.

Region

Buy from your country's storefront

Nurosym serves UK and European markets; Nuropod serves the United States, Canada, Australia and New Zealand. The device is shared, but price, warranty handling and regulatory status follow the storefront.

Safety

Read contraindications before ordering

Implanted electronic devices and other listed conditions can make unsupervised electrical stimulation unsuitable.

Returns

Know which clock applies

Nurosym allows a return request within 30 days after the device arrives, with return shipping paid by the customer. Nuropod's FAQ describes a 37-day window counted from the order.

Common questions

Frequently asked questions

Transparency

Transparency and sources

Researched by Longevity.io

Reviewed

Directory listings are for informational purposes only. Inclusion does not constitute endorsement. Verify credentials and qualifications independently.

Keep exploring

Your Longevity Blueprint

Build your starting plan.

A few short questions, about two minutes. The Blueprint recommends where to start and explains why.

Build my Blueprint